ArticleCancer biology & medicine2023

The inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancer.

Xiaohui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.